Bioxytran's Breakthrough Broad-Spectrum Antiviral Technology Poised to Revolutionize Respiratory Infection Treatment

Stock Information for Bioxytran Inc

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Bioxytran Inc

Bioxytran Announces Initiation of Coverage of its Stock by Independent Research
Bioxytran Completes Randomized Clinical Trial For its Broad-Spectrum Antiviral Drug
Bioxytran Unveils Revolutionary Precision Diagnostics on Tissue Oxygenation
Bioxytran Secures a Source of GMP Quality Camel Hemoglobin
Presenting on Emerging Growth Conference 83 Day 2 on June 18; Register to live stream
Bioxytran's Groundbreaking Stroke & Alzheimer's Tech Gains Validation That Measures Oxygenation Uptake During Strokes
Bioxytran's Antiviral Breakthrough Featured in University of Georgia's $100M HPAI Poultry Innovation Grand Challenge Submission
Presenting on Emerging Growth Conference 82 Day 2 on May 22; Register to live stream

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.